Sector portfolio · VC firm · United States

Morgenthaler Ventures' Biotech portfolio

Morgenthaler Ventures has backed 14 Biotech startups in rounds we track, $1.3B between them, shown by the stage each has reached. The best-funded is Setpoint Medical.

14startups backed
3stages
$1.3Braised between them
Series C and laterbiggest stage

Morgenthaler Ventures's whole portfolioMorgenthaler Ventures's profile

Series C and later

7

Stage not reported

5

Series B

2

Segment by segment

Series C and later

7 startups · $801M raised

  1. SetPoint MedicalSetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies fUnited States$256M
  2. MoximedMoximed Inc.United States$146M
  3. OBOptiScan BiomedicalUnited States$121M
  4. Elcelyx TherapeuticsElcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.United States$117M
  5. Calithera BiosciencesCalithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.United States$115M
  6. NanoOptoNanoOpto employs nano-optics and nano-manufacturing technologies to develop components for optical systems and networks.United States$24M
  7. LLumendLumend is a Health Care company.-$23M

Stage not reported

5 startups · $382M raised

  1. NuvairaNuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.United States$115M
  2. VVertiFlexUnited States$107M
  3. Principia BioPharmaPrincipia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.United States$90M
  4. FLForSight LabsForSight Labs focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients.United States$67M
  5. Mosaic BiosciencesMosaic Biosciences is a biotechnology research company based in Boulder, Colorado, founded in 2009.United States$3.3M

Series B

2 startups · $114M raised

  1. Ra PharmaceuticalsRa Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.United States$77M
  2. SciodermScioderm, a clinical stage pharmaceutical company, develops topical products for the treatment of chronic skin diseases.United States$37M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Morgenthaler Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Morgenthaler Ventures44 co-investorsPortfolio mapMorgenthaler Ventures portfolio map35 startups · $3.8BSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179B

Raising from investors like Morgenthaler Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps